Literature DB >> 8058768

Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.

P M Guy1, J V Platko, L C Cantley, R A Cerione, K L Carraway.   

Abstract

Protein kinases share a number of highly conserved or invariant amino acid residues in their catalytic domains, suggesting that these residues are necessary for kinase activity. In p180erbB3, a receptor tyrosine kinase belonging to the epidermal growth factor (EGF) receptor subfamily, three of these residues are altered, suggesting that this protein might have an impaired protein tyrosine kinase activity. To test this hypothesis, we have expressed human EGF receptor and bovine p180erbB3 in insect cells via baculovirus infection and have compared their autophosphorylation and substrate phosphorylation activities. We have found that, while the EGF receptor readily undergoes EGF-stimulated autophosphorylation and catalyzes the incorporation of phosphate into the model substrates (E4Y1)n (random 4:1 copolymer of glutamic acid and tyrosine) and GST-p85 (glutathione S-transferase fusion protein with the 85-kDa subunit of phosphatidylinositol 3-kinase), p180erbB3 autophosphorylation and substrate phosphorylation are at least 2 orders of magnitude less efficient. However, p180erbB3 is capable of binding the ATP analog 5'-p-fluorosulfonylbenzoyladenosine, indicating that the lack of observed kinase activity is probably not due to nonfunctional or denatured receptors expressed by the insect cells. On the basis of these results, we propose that p180erbB3 possesses an impaired intrinsic tyrosine kinase activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058768      PMCID: PMC44559          DOI: 10.1073/pnas.91.17.8132

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

Review 1.  Growth factor receptor tyrosine kinases.

Authors:  Y Yarden; A Ullrich
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

Review 2.  The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.

Authors:  S K Hanks; A M Quinn; T Hunter
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

3.  Growth factor control of epidermal growth factor receptor kinase activity via an intramolecular mechanism.

Authors:  J G Koland; R A Cerione
Journal:  J Biol Chem       Date:  1988-02-15       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase.

Authors:  J C Tan; K Nocka; P Ray; P Traktman; P Besmer
Journal:  Science       Date:  1990-01-12       Impact factor: 47.728

6.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

7.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

8.  ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor.

Authors:  S P Soltoff; K L Carraway; S A Prigent; W G Gullick; L C Cantley
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

9.  Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.

Authors:  M H Kraus; W Issing; T Miki; N C Popescu; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

10.  Expression of the human EGF receptor with ligand-stimulatable kinase activity in insect cells using a baculovirus vector.

Authors:  C Greenfield; G Patel; S Clark; N Jones; M D Waterfield
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

View more
  212 in total

1.  The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing.

Authors:  H Waterman; I Alroy; S Strano; R Seger; Y Yarden
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

Review 2.  Roles of ErbB-3 and ErbB-4 in the physiology and pathology of the mammary gland.

Authors:  K L Carraway; C A Carraway; K L Carraway
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

Review 3.  The ErbB signaling network: receptor heterodimerization in development and cancer.

Authors:  M A Olayioye; R M Neve; H A Lane; N E Hynes
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

Review 4.  ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling.

Authors:  R Pinkas-Kramarski; I Alroy; Y Yarden
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

Review 5.  Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling.

Authors:  Joyce A Schroeder; Leslie F Jackson; David C Lee; Todd D Camenisch
Journal:  J Mol Med (Berl)       Date:  2003-06-25       Impact factor: 4.599

Review 6.  Evolution of signal transduction by gene and genome duplication in fish.

Authors:  Jean-Nicolas Volff; Manfred Schartl
Journal:  J Struct Funct Genomics       Date:  2003

7.  Substitution of C-terminus of VEGFR-2 with VEGFR-1 promotes VEGFR-1 activation and endothelial cell proliferation.

Authors:  Rosana D Meyer; Amrik Singh; Fredric Majnoun; Catharina Latz; Kameran Lashkari; Nader Rahimi
Journal:  Oncogene       Date:  2004-07-15       Impact factor: 9.867

Review 8.  The ERBB network: at last, cancer therapy meets systems biology.

Authors:  Yosef Yarden; Gur Pines
Journal:  Nat Rev Cancer       Date:  2012-07-12       Impact factor: 60.716

9.  ERBB3: Multifunctional enabler or primary actor in pancreatic cancer?

Authors:  Ralf Landgraf
Journal:  Cancer Biol Ther       Date:  2010-09-13       Impact factor: 4.742

10.  Listeria monocytogenes produces a pro-invasive factor that signals via ErbB2/ErbB3 heterodimers.

Authors:  Maria José Oliveira; Tineke Lauwaet; Georges De Bruyne; Marc Mareel; Ancy Leroy
Journal:  J Cancer Res Clin Oncol       Date:  2004-10-08       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.